The Board of Directors of Dr. Lal PathLabs is scheduled to meet on October 31, 2025, to consider and approve the Un-audited Financial Results for the Quarter and Half Year ended September 30, 2025 (Q2). The board will also consider the declaration of a 2nd Interim Dividend, if any, on the equity shares and a potential issuance of bonus shares, subject to shareholder approval. The trading window is closed until November 2, 2025.
Board Meeting Announcement
A meeting of the Board of Directors of Dr. Lal PathLabs is scheduled for October 31, 2025. Key items on the agenda include the review and approval of the company’s financial performance and potential shareholder benefits.
Key Agenda Items
The board will deliberate on the following:
Trading Window Closure
The trading window for dealing in the company’s securities is currently closed and will remain so until November 2, 2025.
Source: BSE
